IPO VIJAYA DIAGNOSTIC CENTRE LIMITED IPO
IPO :: VIJAYA DIAGNOSTIC CENTRE LIMITED
KEY FACTOR
- In 1981, Promoter and Chairman, Dr. S. Surendranath Reddy established the first Vijaya Diagnostic Centre in Hyderabad
- One of the fastest-growing diagnostic chain by revenue for fiscal year 2020
- offer a one-stop solution for pathology and radiology testing services to our customers through our extensive operational network
- Vijaya Diagnostic Centre (VDC) is India’s largest comprehensive diagnostic network with over 80 state-of-the-art centres spread across 13 cities.
- Company derived 95.91% and 96.20% of our revenue from operations from our core geographies, Hyderabad and rest of Telangana and Andhra Pradesh, respectively
- Grow at CAGR o f around 12% to 13% to reach approximately ₹ 920 billion to ₹ 980 billion by fiscal year 2023
- We offer a comprehensive range of approximately 740 routine and 870 specialized pathology tests and approximately 220 basic and 320 advanced radiology tests that cover a range of specialties and disciplines, as of June 30, 2021.
IPO DETAILS
Details | Info | |
IPO OPEN | आपण या तारखेपासून IPO ला APPLY करू शकतात | 1st September 2021 |
IPO CLOSES | या तारखेला IPO बंद होईल | 3rd September 2021 |
SINGLE SHARE PRICE | एका शेअर ची किंमत | Rs.522- 531 |
FACE VALUE | FACE VALUE | Rs. 1 |
Minimum Lot | कमीत कमी एवढे शेअर्स घ्यावे लागतील | 28 shares |
Minimum Investment | एकूण गुंतवणूक | Rs. 14,868 |
Restated Consolidated Balance Sheet
Vijaya Diagnostic Centre diagnostic network
No. of Centers
City/ Region | 2021 | 2020 | 2019 |
| No. of Centers | ||
Hyderabad | 63 | 58 | 46 |
Rest of Telangana and Andhra Pradesh | 15 | 13 | 12 |
Others | 2 | 2 | 3 |
Revenue From Center
City/ Region | 2021 | 2020 | 2019 |
Hyderabad | 3,041.86 | 2,896.85 | 2,490.93 |
Rest of Telangana & AP | 582.31 | 370.98 | 279.30 |
Others | 143.30 | 120.38 | 155.65 |
Total | 3,767.46 | 3,388.21 | 2,925.87 |
key competitive strengths include
- largest and fastest growing diagnostic chain with dominant position in south India (Source: CRISIL Report), well
- positioned to leverage the high growth in Indian diagnostics industry;
- integrated diagnostics provider that offers one-stop solution at affordable price with focus on superior quality standards;
- high brand recall driving high individual consumer business share and customer stickiness;
- strong technical capabilities, quality infrastructure and state of the art medical technology with strong IT infrastructure;
- dedicated management team with significant industry experience.
Basis of Allotment Date | IPO Allotment दिनांक | 08-09- 2021 |
Initiation of Refunds | पॆसे कधी परत मिळणार | 09-09- 2021 |
Credit of Shares to Demat | शेअर तुमच्या डिमॅट ला या तारखेला जमा होणार | 13-09- 2021 |
IPO Listing Date | IPO Listing दिनांक | 14-09- 2021 |
